https://www.selleckchem.com/pr....oducts/l-arginine-l-
For 8 studies comparing EBL (n = 143) versus APC (n = 174), there was no difference in baseline patient characteristics. However, endoscopic success was significantly higher for EBL [OR 6.04 (95 % CI 1.97 to 18.56; P = 0.002], requiring fewer treatment sessions (2.56 ± 0.81 versus 3.78 ± 1.17; P 0.05. Conclusions EBL appears to be safe and effective for treatment of GAVE, with improved outcomes when compared to APC.Background and study aims Computer-aided diagnostic tools using deep neural networks are efficient fo
Gusto
Magkomento
Ibahagi
